Vemurafenib in combination with cobimetinib in relapsed and refractory extramedullary multiple myeloma harboring the BRAF V600E mutation von Mey, Ulrich J.M., Renner, Christoph, Moos, Roger

Volltext

Improved survival of older patients with multiple myeloma in the era of novel agents von Mey, Ulrich J. M., Leitner, Christoph, Driessen, Christoph, Cathomas, Richard, Klingbiel, Dirk, Hitz, Felicitas

Volltext

Bendamustine, lenalidomide and dexamethasone (BRd) has high activity as 2 super(nd)-line therapy for relapsed and refractory multiple myeloma - a phase II trial von Mey, Ulrich JM, Brugger, Wolfram, Schwarb, Heike, Pederiva, Stefanie, Schwarzer, Andreas, Dechow, Tobias, Jehner, Paul, Rauh, Jacqueline, Taverna, Christian J, Schmid, Mathias, Schmidt-Hieber, Martin, Doerfel, Steffen, Fischer, Natalie, Ruefer, Axel, Ziske, Carsten, Knauf, Wolfgang, Cathomas, Richard, Moos, Roger, Hitz, Felicitas, Sauter, Rafael, Hiendlmeyer, Elke, Cantoni, Nathan, Bargetzi, Mario, Driessen, Christoph

Volltext

SAKK 65/08: A Phase I Dose Escalation Study of Bortezomib in Combination with Nelfinavir in Patients with Advanced Hematologic Malignancies von Driessen, Christoph, Bader, Jürgen, Kraus, Marianne, Jörger, Markus, Rosing, Hilde, Berthod, Gregoire, Hitz, Felicitas, Berset, Catherine, Xyrafas, Alexandros, Hawle, Hanne, Overkleeft, Hermann S, Sessa, Christiana, Huitema, Alwin, Mey, Ulrich JM, Pabst, Thomas, von Moos, Roger, Hess, Dagmar

Volltext

Rituximab Plus Lenalidomide Improves the Complete Remission Rate in Comparison with Rituximab Monotherapy in Untreated Follicular Lymphoma Patients in Need of Therapy. Primary Endp... von Kimby, Eva, Martinelli, Giovanni, Ostenstad, Bjorn, Mey, Ulrich JM, Rauch, Daniel, Wahlin, Björn E, Hitz, Felicitas, Hernberg, Micaela, Johansson, Ann-Sofie, Brown, Peter de Nully, Hagberg, Hans, Ferreri, Andrés J.M., Lohri, Andreas, Novak, Urban, Zander, Thilo, Bersvendsen, Hanne, Bargetzi, Mario, Mingrone, Walter, Krasniqi, Fatime, Dirnhofer, Stephan, Hawle, Hanne, Berardi, Simona, Demmel, Steffi, Rondeau, Stephanie, Zucca, Emanuele

Volltext

Multicenter Phase II Trial of Bendamustine, Lenalidomide and Dexamethasone (BRd) As 2nd-Line Therapy for Multiple Myeloma von Mey, Ulrich JM, Brugger, Wolfram, Bargetzi, Mario, Schwarb, Heike, Schwarzer, Andreas, Dechow, Tobias, Jehner, Paul, Rauh, Jacqueline, Taverna, Christian J., Schmid, Mathias, Schmidt-Hieber, Martin, Doerfel, Steffen, Fischer, Natalie, Ruefer, Axel, Ziske, Carsten, Knauf, Wolfgang, Nusch, Arnd, Cathomas, Richard, von Moos, Roger, Hiendlmeyer, Elke, Hitz, Felicitas, Driessen, Christoph

Volltext